Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timolol Nasal Spray for Epistaxis in HHT
NCT02484716Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jun 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of timolol maleate gel + placebo in hereditary hemorrhagic telangiectasia (HHT), sponsored by Hospices Civils de Lyon. Started Jun 2015; status: completed.
02
Drugs
timolol maleate gel + placebo
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)
Beyond the preview
Go deeper on NCT02484716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02484716.